Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Microbiome confounders research complicates control groups

Nov. 5, 2020

BiomX begins first-in-human study of BX-002 phage therapy for IBD

Nov. 4, 2020

Sichuan Kelun-Biotech Biopharmaceutical discovers CCR2/CCR5 antagonists

Nov. 2, 2020

Subcutaneous lirentelimab demonstrates sustained eosinophil suppression in phase I trial

Oct. 26, 2020

Targeting liver repair with an RSPO mimetic

Oct. 26, 2020

Enrollment ongoing in phase I study of ALN-HSD

Oct. 26, 2020

Adalimumab s.c. efficacious and safe option for children with ulcerative colitis

Oct. 23, 2020

Preclinical data presented on intranasal oxytocin formulation for IBS

Oct. 23, 2020

First-in-human data presented for JAK3 inhibitor TD-5202

Oct. 23, 2020

FDA clears IND for trials of ASC-42 for NASH

Oct. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...